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Overview
When fully implemented in January 2014, the Patient Protection and Affordable
Care Act (Affordable Care Act) will transform the health insurance market for
people with disabilities, enabling them to secure access to more affordable coverage. Beyond the threshold issue of access, however, lies an equally important question: whether coverage will be appropriate to their health and health care needs or
will leave them at risk for insufficient and ineffective care along with significant
out-of-pocket financial exposure.
To avoid this, the Affordable Care Act breaks new ground by directly
addressing the content of coverage through the concept of “essential health benefits.” The law establishes an essential health benefits framework in two distinct
markets. The first is the market for qualified health plans sold through state
health insurance exchanges to individuals and small-employer groups. The second
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is the general market for individual and small-group
health plans, whether sold as qualified health plans
through state health insurance exchanges or outside of
the state exchange structure in what might be thought
of as a parallel, state-regulated market.
Whether sold inside or outside an exchange,
plans sold in the individual and small-group markets
will be regulated by the state within the same general
rules, and will be available, if not marketed, to the
same groups of individuals—namely those without
employer-sponsored coverage and those who work
for small employers. Embedded within this essential
health benefits framework is a prohibition against coverage discrimination based on disability. (While there
are other prohibited grounds for discriminating in the
essential benefits statute, we focus on disability in this
issue brief, because disabling conditions are emblematic
of the types of higher health cost risks that in turn trigger insurers’ exclusionary coverage practices.) How this
nondiscrimination framework advances prior federal
laws and will be implemented as part of essential health
benefits policy can be expected to emerge as a central
issue in the implementation of the reform law.
This issue brief examines the Affordable Care
Act’s essential health benefits statute and considers
its provisions both separately and in relation to prior
federal laws that address health insurance. We explore
the concept of coverage discrimination and the various
techniques of plan design and administration that can
produce discriminatory effects against people with disabilities. We then examine how the reform law’s essential benefits statute builds on existing federal laws that
relate to health insurance and disability discrimination
and discuss how implementation of the essential benefits statute might be approached.

THE ESSENTIAL BENEFITS STATUTE
When fully implemented in 2014, the Affordable Care
Act will establish a range of reforms under various federal laws that are intended to make insurance coverage
fairer and more accessible to individuals with heightened health needs. Among other things, the law will:
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•

prohibit discrimination in coverage based on
health status—that is, prohibit plans from denying coverage to individuals, and from utilizing
varying health insurance premiums, based on
factors other than family size, region, age, or
whether the individual participates in wellness
programs;

•

bar the use of preexisting condition exclusions;
guarantee the renewability of coverage;

•

bar lifetime and annual limits on coverage;

•

establish medical-loss ratio standards;

•

prohibit cost-sharing for certain preventive services; and

•

require coverage of routine patient costs associated with certain clinical trials.

These reforms alone will not ensure the
adequacy of coverage in relation to health care need.
Nor will they prevent insurers from designing coverage—including benefits, cost-sharing, and provider
networks—in ways that attract and better serve healthier individuals with lower financial risks. Moreover,
without provisions aimed at standardizing the content of coverage, it is very difficult for individuals and
small-employer groups—the prime beneficiaries of the
Affordable Care Act’s market reforms—to make meaningful comparisons among coverage options. The need
for some level of product standardization has long been
recognized as a key element in making a health insurance market work.
For this reason, the law also broadly defines
what benefits need to be covered through policies
offered in the individual and small-group markets.
Under the Public Health Service Act (PHSA) as
amended by the Affordable Care Act, all insurers operating in the individual and small-group markets must
cover an “essential health benefits” package.
The Affordable Care Act further directs that
qualified health plans sold in state health insurance
exchanges (including co-op plans) cover these essential
health benefits.

The Essential Health Benefits Provisions of the Affordable Care Act
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Exhibit 1. Essential Benefit Classes Covered by Qualified Health Plans Under the Affordable Care Act
• Ambulatory patient services
• Emergency services
• Hospitalization
• Maternity and newborn care
• Mental health and substance use disorder services
• Prescription drugs
• Rehabilitative and habilitative services and devices
• Laboratory services
• Preventive and wellness services
• Chronic disease management
• Pediatric services, including oral and vision care
Source: Authors’ analysis of the Affordable Care Act.

The law also establishes cost-sharing limits
with respect to the overall actuarial value of the plan,
the total amount of cost-sharing to which individuals
and families can be exposed, and the size of the annual
deductible that must be met.
Finally, it amends the Employee Retirement
Income Security Act (ERISA) to apply these provisions, codified in the PHSA provisions to ERISAgoverned employer groups.
The act exempts large-group health plans,
as well as self-insured ERISA plans and ERISAgoverned multiemployer welfare arrangements not
subject to state insurance law, from the essential benefit
requirements.
The term “essential health benefits” is defined
as a series of broad benefit classes, with considerable
discretion left to the Secretary of the U.S. Department
of Health and Human Services (HHS) to further
define the concept (Exhibit 1). Qualified health plans
are not barred from offering additional benefits, and
states may require that qualified health plans sold in
state health insurance exchanges also cover state-mandated benefits.
Where a state mandate adds an entirely new
benefit class to qualified health plans sold in exchanges,
a state must pay the cost differential for coverage of
these benefits.

How treatments subsumed within an essential
benefit class will be treated when applied to exchange
products has not yet been determined.
Although the essential benefits statute vests
discretion in the HHS secretary, the law also sets
boundaries on how she exercises that discretion, shown
in Exhibit 2 and excerpted below. These boundaries
consist of certain elements related to public notice and
comment, inclusion of treatments and services falling
within the essential health benefits package, consultation with the Secretary of Labor on establishing coverage parameters based on a Department of Labor survey
of “typical” employer plans, and a series of “required
elements for consideration.”1
Specifically, the law states that the HHS secretary must “ensure that such essential health benefits
reflect an appropriate balance among the categories . . .
so that benefits are not unduly weighted toward any
category.”2 Second, the secretary may “not make coverage decisions, determine reimbursement rates, establish
incentive programs, or design benefits in ways that discriminate against individuals because of their age, disability, or expected length of life.”3 Third, the secretary
must take into account “the health care needs of diverse
segments of the population, including women, children,
persons with disabilities, and other groups.”4 Fourth,
the secretary must ensure that essential benefits “not
be subject to denial to individuals against their wishes
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Exhibit 2. Parameters That Guide the HHS Secretary’s Determination of an Essential Benefits Package
Benefit classes: Certain classes of benefits must be represented in the essential benefits package.
Scope of benefits: Essential health benefits must be equal in scope to benefits provided under a typical employer plan.
Certain elements must be considered: Elements that must be considered include: the balance among benefit categories;
nondiscrimination against individuals because of their age, disability, or expected length of life; the health care needs of
diverse segments of the population; and the fact that benefits cannot be subject to denial on the basis of an individual’s
age or expected length of life or the individual’s present or predicted disability, degree of medical dependency, or quality
of life.
Cost-sharing: The law includes broad limits on cost-sharing, including deductibles, coinsurance, copayments, or similar
charges.
Utilization management: The HHS secretary cannot prohibit a group health plan or health insurance issuer from carrying
out commonly used utilization management techniques.
Source: Authors’ analysis of the Affordable Care Act.

on the basis of the individuals’ age or expected length
of life or the individuals’ present or predicted disability,
degree of medical dependency, or quality of life.”5
The essential health benefits definition also
addresses cost-sharing, defined as “deductibles, coinsurance, copayments or similar charges.”6 These provisions address both the limits on annual cost-sharing as
well as how these limits will be applied in relation to a
four-tier cost-sharing coverage structure. This structure
ranges from “bronze” plans (covering 60 percent of the
full actuarial value of benefits provided) to “platinum”
plans (covering 90 percent of the full actuarial value).
(A fifth level of coverage pertaining to catastrophic
plans may be sold to individuals under age 30 or others
who are certified by the exchanges as not having access
to affordable coverage, as defined in the statute.7) The
concept of a plan’s actuarial value is defined as the level
of coverage determined by the secretary based on the
essential health benefits covered.8
The law also contains the following limitation
on the HHS secretary’s discretion to define an essential
benefits package: “Notwithstanding any other provision
of the . . . Act, nothing . . . shall be construed to prohibit (or authorize the Secretary of Health and Human
Services to promulgate regulations that prohibit) a
group health plan or health insurance issuer from carrying out utilization management techniques that are
commonly used as of the date of enactment of this
Act.”9 The term “utilization management techniques” is
not defined.

Taken together, the Affordable Care Act’s
essential benefits provisions set out a multipronged
decisional framework. First, they establish certain broad
benefit classes that serve as anchors for the definition
of an essential health benefits package. Second, they
empower the HHS secretary, rather than health insurers, to define the essential benefits package, in consultation with the Labor secretary and on a nonreviewable
basis (“as determined by the Secretary”). Third, the
provisions peg the benefits to a “typical” employer plan
while at the same time barring the HHS secretary from
making coverage decisions, determining reimbursement
rates, establishing incentive programs, or designing
benefits in ways that discriminate on the basis of age,
disability, or expected length of life. Finally, the law
bars the secretary from prohibiting group health plans
or health insurers from employing “utilization management techniques” that are “commonly” used, while leaving both terms undefined.
The essential health benefits framework raises
important issues. To the extent that current “typical”
coverage practices by group health plans discriminate
on the basis of disability, the secretary nonetheless is
obligated to ensure that such discriminatory practices
are not carried over into the individual, small-employer
group, and qualified health plan markets. But this provision raises the question of what “typical” employer
practices consist of. Furthermore, how will the terms
“coverage decisions,” “reimbursement rates,” “incentive
programs,” and “benefit design” be defined in terms of
the provision that bars the secretary from using such
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tools in ways that would discriminate against people
on the basis of age, disability, or expected length of life.
Finally, what are the “utilization management” techniques the secretary is barred from prohibiting?

COVERAGE DESIGN AND UTILIZATION
MANAGEMENT PRACTICES IN THE
EMPLOYER GROUP MARKET
The starting point for determining how the essential
health benefits package ultimately will be defined is the
employer group market. It is thus useful to understand
the techniques used by insurers operating in this market to manage costs and thereby limit their exposure to
the financial risks associated with claims for coverage.
To the extent that these techniques result in disability
discrimination, the Affordable Care Act’s essential
benefits framework can be expected to curtail or modify these practices.
Insurers’ strategies for managing risk are
highly complex and extend well beyond simply offering a broader versus narrower range of benefit classes
or instituting a prior authorization process for certain
treatments. For example, how a particular benefit is
defined may affect its availability in particular cases.
Furthermore, within any covered benefit class there
exist thousands of specific procedures that may or may
not be covered. For example, a prescription drug formulary may exclude certain classes or types of drugs
from coverage altogether. Provider networks may
be designed to attract and enlist providers that treat
lower-cost patients. Provider payment and incentive
plans may encourage short-term treatment while discouraging longer-term interventions. Key terms that
govern the availability of all benefits, such as “medical
necessity” or “experimental,” also can affect whether
coverage is available for a particular condition. The use
of certain types of exclusionary terms, such as “educational” or “social,” can bar otherwise-available coverage.
Because the Affordable Care Act specifies
that the HHS secretary utilize the “typical” employee
health benefits plan as the starting point for determining the scope of the essential health benefits package, it
is important to understand how discrimination against
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people with disabilities and more advanced health
needs can occur in such plans. In this context, the concept of discrimination is meant to denote practices that
limit insurers’ cost exposure in the case of members
with high health care needs. Because the Affordable
Care Act’s market reform provisions effectively bar
discrimination at the point of enrollment, efforts to
constrain costs at the point of coverage and use become
all the more important to understand.10
Insurers’ approaches to managing risk include:
1) techniques related to the design of benefits and
coverage; and 2) techniques related to managing the
utilization of covered benefits.11 Coverage and benefit
design techniques can limit or exclude coverage outright, much in the way that an annual dollar limit on
the value of coverage would place a hard limit on coverage, regardless of need. Such techniques apply to all
members enrolled in a particular plan and are intended
to exclude certain types of coverage altogether, regardless of the characteristics of the individual who seeks
care.12 In effect, design features act as fixed limitations
and restrictions on the “amount, level, extent or nature
of benefits or coverage for similarly situated individuals
enrolled under the plan.”13 These types of limits cannot be challenged with medical evidence showing that
more or different treatments are necessary; coverage is
not available regardless of the merits of the claim.
The second set of coverage risk management
techniques relates to utilization management, that is,
techniques used by health insurers to manage the use of
covered benefits in the case of individual patients.14 In
this regard, the Affordable Care Act requires the HHS
secretary to recognize existing utilization management
techniques in use at the time of passage, although such
techniques presumably would be subject to the law’s
broad nondiscrimination provisions.
The various types and range of coverage and
benefit design limitation techniques, as well as utilization management techniques, can be found in the
health insurance literature.15 Another and perhaps even
more useful source of evidence on these techniques is
the large body of judicial case law involving appeals of
benefit denials under ERISA and other laws governing health insurance and employee health benefits.16
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Because the judicial record is comprehensive and public, it is possible to view with particularity the specific
risk-avoidance techniques used by group health plans.
While these cases do not shed light on the frequency
with which certain types of claims are denied, the decisions provide understanding of the design and management techniques that are available to group health plans.

Benefit and Coverage Design Limitation
Techniques
One of the largest trends in care and cost management
in recent years has been the use of benefit and coverage design to manage risk. Initially, in the late 1980s,
insurers testing cost-containment strategies tended to
use broadly crafted coverage documents coupled with
individual patient management, such as prospective
and concurrent utilization management procedures.17
Eventually, this approach proved to be ineffective at
containing costs. As a result, over the past two decades,
far greater attention has been focused on the design
of the plan documents that describe what is covered
in order to tighten the coverage criteria and thereby
exclude certain types of treatments and procedures.
Design strategies also utilize financial techniques such
as patient cost-sharing and payment incentives aimed
at encouraging more efficient practices and care-seeking behavior.18
What sets plan design cost containment apart
from utilization management efforts is that the denial
of coverage is based on a specific limitation or exclusion that is not specific to an individual’s health condition or treatment needs, and thus cannot be challenged.
Under traditional employee health benefit plan principles and in the absence of specific legal requirements,
employers that sponsor health plans are considered
to have unlimited discretion to exclude coverage. By
contrast, in cases involving patient-specific utilization
management denials, the claim denial rests on a determination that a particular benefit is not necessary for a
particular patient. The latter decision rests on medical
evidence and factual issues at play, giving rise to appeals
rights. But where a claim denial is based on an administrator’s assertion that a particular benefit is excluded

The Commonwealth Fund

altogether under the terms of a plan, the result is total
exclusion regardless of individual circumstances, and no
appeal can be mounted.19

Coverage exclusions and limitations. A

claim denial can stem from an across-the-board coverage exclusion, embedded in the plan document, that
excludes specific services and procedures in all cases.
Exclusions can be expressed in durational or quantity limits (e.g., no more than 30 speech therapy sessions) or be tied to specific procedures or treatments.
For example, prior to passage of the Women’s Cancer
Recovery Act of 1998, breast reconstruction following
mastectomy was considered cosmetic and was routinely
and explicitly excluded from coverage.20
Exclusions also can be condition- or diagnosisbased. For example, otherwise-covered speech and
physical therapy might be excluded in cases in which
the purpose of the treatment is to recover lost functioning or restore previous levels of functioning. In such a
situation the “recover” limitation is embedded in the
coverage definition itself (e.g., “speech therapy when
needed to restore prior functioning”) or in a broader
medical necessity definition that defines medical necessity as existing only when a treatment has the potential
to aid in recovery.21
In addition, coverage exclusions can be purpose-based. For example, an exclusion may be applied
against coverage of otherwise-covered physical therapy
where the insurer determines that the purpose of the
therapy goes beyond clinical value and also will aid
in broader health goals such as education or social
and job-based functioning. This type of exclusion is
sometimes applied when a child with developmental
disabilities present at birth is receiving treatment that
has clinical value as well as the added value of allowing the child to develop speaking and movement skills
that ultimately can be expected to result in an overall
improvement in health and functioning.22 In those
cases, an insurer may deny coverage because the therapy
has an educational benefit, as well as a clinical benefit.

The Essential Health Benefits Provisions of the Affordable Care Act

Coverage and treatment guidelines
incorporated into the plan’s terms of coverage.
Health plans make extensive use of benefit and clinical guidelines to inform coverage decision-making. In
some cases, the guidelines are used by an insurer to
guide decisions but are not part of the plan documents
themselves and thus do not bind a plan administrator
to award or deny a benefit based on individual circumstances. In other cases, however, guidelines are incorporated into the plan documents as part of the coverage
terms and thus create express limits on the types of
treatments that can be covered. The guidelines express
the full breadth and scope of treatment under the terms
of the plan.23 For example, medical management guidelines might specify coverage of long-term treatment
for alcohol addiction only in situations in which shortterm treatments have failed—thus barring the use of
longer-term treatments even in situations in which a
short-term treatment is clinically inappropriate, given a
patient’s underlying health condition.24

Definitions of key benefit and coverage
terms. How plan documents define benefit classes can

determine whether coverage is available. For example,
where a plan’s terms define speech therapy as therapy
needed to recover lost speech or restore speech, the
effect is to exclude coverage for a child or adult whose
health condition can benefit from therapy but for
whom prior functioning cannot be “restored.” This type
of example has particular resonance for children born
with developmental disabilities and who need therapy
to attain speech, or adults with muscular dystrophy
who need therapy to maintain speech or avert the loss
or deterioration of speech.25 In both cases, the therapy
is clinically indicated as an effective health intervention, but coverage is excluded because the intervention
in the patient’s case falls outside the terms of coverage.
In a similar vein are medical necessity definitions that apply to all covered treatments and procedures and that limit coverage to services that are
required for the treatment of “illness, injury, diseased
condition, or impairment.”26 Such a framework may
exclude some conditions. For example, a “diseased
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To the extent that current
“typical” coverage practices by group
health plans discriminate on the
basis of disability, the HHS secretary
nonetheless is obligated to ensure
that such discriminatory practices are
not carried over into the individual,
small employer group, and qualified
health plan markets.

condition” as a concept could be construed narrowly
to exclude physical and mental health conditions that
are not considered by clinical experts to be the product
of a disease but are instead determined to be present
at birth.

Tiered cost-sharing. Creating different lev-

els, or tiers, of cost-sharing has gained popularity as
a way to provide incentives for the appropriate use of
care.27 In tiered cost-sharing arrangements, higher-cost
treatments and services (e.g., brand-name prescription drugs, a specific type of operation performed
by an out-of-network surgeon) are subject to higher
cost-sharing when, in the health plan’s determination,
a lower-cost treatment or in-network provider would
provide equally effective treatment.28 Similarly, costsharing may be reduced in cases in which adherence to
a particular course of treatment (e.g., use of prescription drugs to control blood pressure) is consistent with
sound clinical practice and good health outcomes.
Tiering decisions may be made on a case-bycase basis or may be subject to practice guidelines that
are embedded in plan documents and coverage terms
and therefore automatically place certain treatments
and procedures on a higher tier.29 Where the tiered
arrangement is the result of a medical management
decision specific to a particular patient, modification to
consider whether the guidelines appropriately address
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that patient’s underlying condition may be possible.
But where the tiered arrangement is the result of a
guideline that is directly embedded into the terms of
coverage, challenges are generally not possible.30

Tiered provider networks.31 Early efforts

by health plans to encourage patients to use efficient,
high-quality providers involved a total exclusion of
certain providers from networks, leaving patients
completely uncovered for out-of-network care. In
recent years, group health plans have moved to a more
nuanced, value-based approach that involves the use
of provider tiers. Providers who have been shown to
have higher costs and/or worse outcomes, as measured
by a health plan, may be subject to higher cost-sharing
or excluded altogether. The lowest cost-sharing levels
are required for health professionals who deliver high
value. Depending on the methodology used to compare
providers, tiering may or may not take into account
whether providers treat patients with more extensive
health needs and thus utilize more resources either in
their own practices or through specialty care referral
patterns. Furthermore, tiers may be determined based
on practice measures that are designed for populations
with health conditions (e.g., diabetes), but without
considering patients whose health conditions are made
more complex by the presence of underlying disabling
conditions (e.g., diabetes and schizophrenia).32

Provider payments. Health plans give pro-

viders several different types of incentives to be parsimonious in their use of resources.33 Incentives may take
the form of a year-end bonus or a shared-savings plan.
Incentive payments may be tied to a provider’s overall
consumption of resources and benefits (e.g., laboratory
tests), and providers may be benchmarked against one
another without taking into account their patient mix.
Providers may be offered bonuses or case management
fees to actively manage complex patients. To determine
such incentive payments, health plans might compare
the costs and outcomes for actual patients or, alternatively, might compare costs and outcomes for a provider’s patient panel against established and normative

The Affordable Care Act’s
essential benefit nondiscrimination
provisions add new dimensions to
prior federal laws regulating insurance
and health plans and barring
discrimination.
benchmarks that may or may not reflect the actual
health status of the provider’s patients.

Utilization Management Techniques
Prospective and concurrent review. Health plans

have used prospective and concurrent review to control costs for decades. These processes are designed to
control unnecessary utilization of covered but costly
resources through advance or concurrent consideration
of the medical necessity of the treatment or service
under review. Central to the review process are: the
substantive standards to assess the need for care; the
strength of the clinical evidence considered; the application of clinical decision-making guidelines to particular treatments, as well as the quality and relevance
of the guidelines to the case at hand; and the extent to
which the reviewer takes into account the clinical evidence that is presented in relation to the case at hand.34

Care coordination and care management.
An insurer or health plan may offer or require case
management for certain types of conditions. In some
cases, the service may be offered in addition to other
covered services. Patients with particular conditions
may be offered additional treatments and counseling,
and their health and course of treatment may be closely
monitored to measure improvement. In other cases, a
disease management protocol may take on the qualities
of an embedded practice guideline that restricts coverage to certain predefined treatments and charges higher
cost-sharing for certain treatments. When implemented in this fashion, care management may operate
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as an exclusive form of coverage for a particular illness
or condition rather than as a process for tailoring covered benefits to individual needs.35

HOW THE NONDISCRIMINATION
PROVISIONS EXTEND EXISTING LAW
The Affordable Care Act’s essential benefits nondiscrimination provisions break new ground in how to
think about these common techniques of health benefit
design and management—adding new dimensions to
prior federal laws regulating insurance and health plans
and barring discrimination. The nondiscrimination
provisions have no real parallel in state insurance laws,
which do not address discrimination in the content of
coverage but instead tend to mandate specific treatments and procedures that otherwise were at risk for
exclusion. For example, no state’s insurance laws bar the
use of a “recover” or “restore” medical necessity standard
in the group health market, but as of 2010, 23 states
have laws that require coverage for certain types of
habilitation treatments aimed at promoting the overall
health of children with autism.36
Although the nondiscrimination provisions
are unprecedented in the context of coverage content, a
number of federal laws offer important precedents.

Federal Laws Regulating Insurance and
Employee Health Benefit Plans
HIPAA. The Health Insurance Portability and

Accountability Act of 1996 (HIPAA) provided the
foundation for the Affordable Care Act’s market
reforms.37 HIPAA was the first major attempt to use
federal law to prevent insurers from discriminating
against people with health conditions and disabilities. Amending the PHSA, ERISA, and the Internal
Revenue Code in order to reach both state-regulated
health insurance and self-insured health benefit plans,
HIPAA bars discrimination based on health status at
the point of enrollment and renewal. In effect, the new
reform law builds on the HIPAA precedent, extending nondiscrimination prohibitions into the individual
market and strengthening existing provisions in the
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group market. But unlike the reform law, HIPAA does
not address the problem of discrimination in the design
and administration of coverage because it does not
address the content of insurance itself.
ERISA. Other than having to abide by the
HIPAA provisions, ERISA generally accords employers broad discretion in health benefit plan design and
administration, regardless of whether the plan is fully
insured (and thus also subject to applicable state laws)
or self-insured (and thus exempt from state laws regulating insurance).38 Thus, for example, although ERISA
contains provisions barring discrimination against
participants or beneficiaries who exercise their right
to benefits, this prohibition has been held not to bar a
group health plan from singling out a specific disability
for express limitation or exclusion from coverage.39
There are important exceptions, however.
For example, ERISA requires that certain individuals
experiencing a “qualifying event,” including illness and
job loss, be permitted to continue to buy group health
coverage under their ERISA plans (a right popularly
known as “COBRA”).40 ERISA also bars exclusion
from coverage of college students on a medically necessary leave of absence.41
Furthermore, ERISA has been amended to bar
discrimination against certain types of patients in terms
of the content of coverage. For example, ERISA prohibits group health plans from excluding coverage for
reconstructive surgery to women with breast cancer or
from covering only minimal hospital stays for pregnant
women and newborns.42 Perhaps most important in the
context of discrimination, ERISA bars discrimination
in coverage in the case of individuals with mental illness or substance use disorders, as discussed below.

GINA. The Genetic Non-Discrimination Act

of 2008 (GINA) bars certain employer and insurer
practices related to the use of genetic information, but
nothing in GINA directly addresses content restrictions that might reduce or eliminate coverage for certain individuals with conditions tied to genetic traits.43
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Mental health and substance use disorder parity. Mental health parity represents the most

important law enacted to date that directly addresses
discrimination in the design and administration of
state-regulated health insurance and ERISA-governed
employer-sponsored health benefit plans. The Mental
Health Parity Act of 1996, revised and expanded by
the Paul Wellstone and Pete Domenici Mental Health
Parity and Addiction Equity Act of 2008, broadly
addresses the problem of discrimination against mental
illness and addiction disorders in both benefit design
and plan administration.44
The original legislation addressed parity only
in relation to annual and lifetime dollar limits on coverage; the 2008 amendments extend the concept of
parity to reach a broad range of coverage limitations
and exclusions. These amendments were further refined
in implementing regulations released in 2010 by the
Departments of Labor, Treasury, and HHS, which
define parity in terms of quantitative treatment limits
(i.e., the number of visits permitted) as well as “nonquantitative” treatment limits that “otherwise limit the
scope or duration of benefits for treatment.”45 These
types of limits lie at the heart of modern benefit design
and medical management systems; in particular, nonquantitative design and management techniques, which
in some cases are expressly designed to constrain coverage to individuals with disabilities.
The 2010 parity regulations affect many of
the health benefit design and management practices
described above. For example, the regulations specify
that discrimination may be present under the parity law when mental illness and addiction disorders
are singled out by guidelines that restrict coverage to
certain treatments, regardless of the medical evidence,
even when no similar absolute limits apply to other
conditions. The rules also clarify that parity can be violated through discriminatory medical necessity criteria
that utilize more restrictive tests of necessity in the case
of mental illness and through other design techniques
such as tiered cost-sharing, tiered network arrangements, and utilization management procedures that are
applied in a discriminatory fashion.46
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The parity provisions thus offer an important
precedent in approaching the essential benefits provisions of the Affordable Care Act. In the case of mental
health parity, the federal agencies not only have directly
addressed the range of plan design and administration
practices, but have identified many types of practices
that must be held to nondiscrimination standards,
including specific benefit definitions, broad definitional
terms such as medical necessity, the use of practice
guidelines, and the use of provider network and costsharing tiers. These strategies are grouped together
as nonquantitative in nature and set the framework
of coverage itself, as well as how that coverage will be
administered.

Civil Rights Laws
The Affordable Care Act directly incorporates numerous civil rights laws into Title I.47 Specifically, it provides that:
An individual shall not, on the ground prohibited under title VI of the Civil Rights Act of
1964, title IX of the Education Amendments of
1972, the Age Discrimination Act of 1975, or
section 504 of the Rehabilitation Act of 1973,
be excluded from participation in, be denied the
benefits of, or be subjected to discrimination
under any program or activity, any part of which
is receiving federal financial assistance, including credits, subsidies, or contracts of insurance,
or any program or activity that is administered
by an Executive Agency or any entity established under this title.48
The provision thus incorporates federal civil
rights laws applicable to federally assisted programs
while also clarifying that these laws reach federally
subsidized contracts of insurance such as qualified
health plans that receive federal premium tax credits.
By incorporating these laws into the Affordable Care
Act, the general nondiscrimination provision further
strengthens the core essential health benefit nondiscrimination statute but does not duplicate it, since civil
rights laws barring discrimination against people with
disabilities have been held not to reach the content of
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coverage itself.49 Preexisting nondiscrimination laws
might be expected to reach insurance and health plan
practices inside exchanges such as: sales, outreach,
and marketing practices; the selection and deselection
of health care providers; the accessibility of care and
appeals procedures; and other issues related to access to
covered benefits. But it is the essential benefits nondiscrimination provisions that affect the actual content of
benefits and do so both in exchange markets as well as
in the parallel market for individual and small-group
products.

DISCUSSION AND IMPLEMENTATION
RECOMMENDATIONS
Implementation of the Affordable Care Act’s essential
benefits provisions and its prohibition against discrimination against individuals with disabilities will raise a
number of complex issues.

Defining Key Terms
An important first step of the implementation process
is for the HHS secretary to define key terms in the
essential benefits provisions. In addition to needing to
define the scope of each class of essential benefits, the
secretary must define such terms as “disability,” “coverage decisions,” “reimbursement rates,” “incentive programs,” and “benefit design.” Also to be further defined
in designing the essential benefits package is how the
secretary will “take into account” the health care needs
of diverse populations, including people with disabilities. Furthermore, the secretary must define the law’s
prohibition against the denial of essential benefits
based on individuals’ “age or expected length of life”
or “present or predicted disability, degree of medical
dependency, or quality of life.” In defining key terms,
the secretary presumably will look to existing laws and
relevant industry practices. For example, existing laws
related to coverage decisions made by group health
plans or Medicare provide guidance on how clinical
evidence should be weighed.
The single most important definitional matter
may be the threshold question of whether prohibited
discrimination on the basis of disability reaches both
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intentional discrimination as well as de facto discrimination—practices that are neutral on their face but
discriminatory in their impact. Because the Affordable
Care Act specifically incorporates existing disability
law, and because existing law reaches both intentional
and de facto discrimination, the essential benefits nondiscrimination provisions should be interpreted in a
fashion that parallels existing disability law. This means
that the provisions should be interpreted as reaching not only intentional practices (such as a coverage
standard that specifies the need for “recovery” before a
claim will be allowed) but also de facto practices such
as the use of facially neutral provider payment incentives that nonetheless discriminate because they are
applied without consideration of a provider’s underlying patients. For example, plans would no longer be
permitted to intentionally exclude providers that have
a special expertise in, and a disproportionate share of,
patients with disabilities. In designing the nondiscrimination aspect of the essential benefits provisions,
Congress clearly intended to reach matters of both plan
design and administration practices, in order to ensure
that plans do not discriminate by either intentional
design or practical effect.

Plan Design and Administration Practices
The nondiscrimination provisions require that the
HHS secretary set the parameters under which insurers
may operate in matters of both design and administration, including benefit design, coverage decisions, reimbursement rates, and incentive programs. The sweeping
language of the nondiscrimination provision means
that, as with the mental health parity rules, the secretary must address certain risk-avoidance techniques
and strategies.

Exclusionary coverage terms. Health insur-

ers and qualified health plans should be expected to
adhere to nondiscriminatory coverage terms in order to
avoid excluding otherwise covered treatments simply
on the basis of a patient’s underlying condition. The
decision of whether a particular treatment or service is
covered should turn solely on whether it is appropriate
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to a patient’s health condition—not whether it will
enable restoration or recovery or have effects that transcend the purely clinical and go to overall health and
ability to function. In the case of children and adults
with disabilities, many treatments within the essential
benefits classes are clinically justified not because they
allow restoration or recovery but because they enable
patients to attain good health, maintain their health, or
avert the loss of functioning that could lead to a deterioration in health.

Excluding coverage for treatments that
show both clinical and health benefits. The

fact that a treatment may confer both clinical and
broader health benefits should be irrelevant in deciding whether it is appropriate. Exclusions based on the
broader health benefits conferred by a clinical intervention (such as the ability to learn, work, or engage in
social activities) are enhancements of the clinical effects
of treatments, not reasons to deny them.

Guidelines and coverage design and decision-making. Benefit and treatment guidelines are a

staple in health plan design and plan administration,
serving two purposes: 1) to set out coverage limits for
certain conditions or for one or more benefit classes;
and 2) to use as a nonbinding tool to aid coverage decision-making in specific cases. In both situations, the
impact of the guideline may be to foreclose potentially
covered treatments within an essential benefit class
at a level and scope necessary to achieve an appropriate health result. Guidelines that contain restrictions
based on whether treatments are intended to help in
“recovery or restoration” would appear to fail under a
nondiscrimination test, for the same reason that such
limits are contrary to a nondiscrimination test when
they appear as limitations in the coverage definitional
sections of an insurance plan. Further, guidelines that
place fixed limits on treatments may be inappropriate in situations in which the condition to which the
guideline is applied is further complicated by the presence of an underlying disability. Thus the management of asthma, for example, may vary depending on
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whether the patient also has an underlying condition
such as major depression or diabetes.
Regardless of whether benefit and treatment
guidelines are used to set binding coverage limits or
merely to guide treatment decision-making, the question is whether the nondiscrimination provision in the
essential benefits statute bars the use of the guideline
to limit treatment when the effect of the guideline is to
discriminate against certain health conditions. Such an
exception is similar to the one that applies to coverage
of outpatient prescription drugs under Medicare Part
D, which permits individuals to appeal coverage denials on the ground of documented health care need and
to submit evidence demonstrating the utility of treatments for a particular condition.50

Across-the-board coverage limitations
and exclusions. Nothing in the Affordable Care Act

prohibits the use of across-the-board limitations on
coverage. While strict limits on the amount or duration
of benefits work particular hardships on individuals
with disabilities, the question is whether such limits
are discriminatory. As long as the limits apply to all
conditions and all treatments, discrimination per se is
not the issue. However, the essential benefits statute
requires the HHS secretary to consider the needs of
people with disabilities in designing benefits and making coverage determinations. This might argue for an
exceptions process to permit greater levels of coverage
in cases in which relevant and reliable evidence demonstrate the health benefits of a treatment. Further,
while across-the-board limitations and exclusions on
an entire benefit class might not be discriminatory,
exclusions that single out specific treatments used only
for specific disabling conditions should be considered a
form of discrimination.

Tiered cost-sharing and provider networks. Tiered cost-sharing and provider networks are

increasingly common design features in health benefit
plans. The use of tiering raises the question of the
need for an evidence-based exception to plan design in
cases where a tier would otherwise result in the denial
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of appropriate treatment based on a health condition
or where a specific provider should be treated as an
in-network provider (with in-network payment rates
and cost-sharing) in order to ensure the appropriate
management of disabling conditions. In essence, the
question is whether the nondiscrimination provision
applicable to essential health benefits, when coupled
with existing civil rights protections, requires that
health plans modify provider network selection and
tiering practices in order to protect against the threat of
discrimination in access to equally effective care.

Provider payment and incentive arrangements. Existing laws aimed at curbing health care

fraud and abuse prohibit incentive arrangements that
induce health professionals to deny or withhold medically necessary treatment.51 However, payment and
incentive arrangements should not be benchmarked
against normative performance with a healthy patient
panel, but instead should be risk-adjusted to take
into account patients with disabilities. As with tiered
cost-sharing and provider networks, this consideration
reflects not only the essential benefit nondiscrimination
provision but also federal civil rights laws that require
access to equally effective health care.

Utilization management techniques. In

addition to addressing the problem of discrimination in
all aspects of benefit and coverage design and practice,
it is important to address potentially discriminatory
utilization management processes. The Affordable
Care Act preserves existing utilization management
practices but does so under the broader nondiscrimination provisions of the essential benefits statute. As such,
and as with the mental health parity regulations, medical management techniques that differentiate based
on the nature of the condition or disability should be
prohibited. Further, the nondiscrimination prohibition
should be extended to the claims appeals process applicable to essential benefits plans in order to ensure that
evidence specific to an individual’s condition and treatment is always taken into account as part of the record.
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Finally, of course, for the nondiscrimination
statute to be meaningful, compliance must be measured and the terms of the law must be enforced. This
means assurance that the nondiscrimination provisions
and implementing standards are incorporated into and
applied to all state insurance contracts governed by the
essential benefits statute. In this way, the requirements
of federal law will become an inherent part of the
documents that create the plan and define the rights of
covered individuals. Further, government enforcement
standards developed for oversight of the individual and
small-group market, as well as the exchange qualified
health plan market, should be structured to measure
plan adherence to nondiscrimination standards. This
structure will necessitate a review of plan documents
and coverage terms, as well as an assessment of plans’
coverage determination, incentives, and payment
practices.
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